| REVIEW |
|
| Year : 2014 | Volume
: 15
| Issue : 2 | Page : 55-60 |
|
|
Beta blockers in infantile hemangiomas: A practical guide
Manish K Shah
Associate Honorary Consultant, Pediatric Dermatology Unit, B. J. Wadia Hospital for Children, Parel, Mumbai, Maharashtra, India
Correspondence Address:
Manish K Shah
Pediatric Dermatology Unit, B. J. Wadia Hospital for Children, Parel, Mumbai, Maharashtra
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/2319-7250.139498
|
|
|
The use of oral and topical beta blockers has revolutionized the management of infantile hemangiomas. Oral propranolol at 2 mg/kg/d in divided doses not only prevents further proliferation, but actually shrinks IH. Propranolol should be administered for at least 6 months or until the baby reaches one year of age. Side effects to be watched out for include hypoglycaemia, bradycardia and hypotension. Oral propranolol should be prescribed only in those IH where clearly indicated. More cardioselective beta blockers like atenolol are also being explored for treating IH. Topical timolol has been prescribed for smaller and superficial IH or when propranolol is contraindicated. |
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
